Mangalam Drugs and Organics Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Mangalam Drugs and Organics Ltd. on BSE

Load latest

Mangalam Drugs and Organics Ltd.

25 Feb 2025

78.77

1.69%

Corp. Note

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Integrated Filing (Financial)

BSE India

Integrated Financials(PDF) for the quarter ended December 31, 2024.

pdf

Mangalam Drugs and Organics Ltd.

15 Feb 2025

78.77

1.69%

Company Update

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper publication of Un-Audited Financial Results for the quarter ended 31st December , 2024 declared in the Board Meeting held on 13th February 2025.

pdf

Mangalam Drugs and Organics Ltd.

13 Feb 2025

78.77

1.69%

Result

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Declaration Of Un-Audited Financial Results For The Quarter …

BSE India

Board meeting held on 13th February 2025 for declaration of Un-Audited Financial Results of the Company For the quarter ended 31st December 2024.

pdf

Mangalam Drugs and Organics Ltd.

13 Feb 2025

78.77

1.69%

Board Meeting

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Outcome for Declaration Of Un-Audited Financial …

BSE India

Declaration of Un-Audited Financial Results for the quarter ended 31st December 2024 in the Board meeting held on 13th February 2025

pdf

Mangalam Drugs and Organics Ltd.

05 Feb 2025, 05:33PM

78.77

1.69%

Board Meeting

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Intimation for Intimation Of Board Meeting …

BSE India

MANGALAM DRUGS & ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to consider and approve Intimation of Board meeting to be held on 13th February 2025 for approval of Un-audited Financial results of the Company for the quarter ended 31st December 2024

pdf

Mangalam Drugs and Organics Ltd.

31 Jan 2025

78.77

1.69%

SAST

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI …

BSE India

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on January 30, 2025 for Shree Kishoriju Trading and Investments Pvt Ltd

pdf

Mangalam Drugs and Organics Ltd.

18 Jan 2025

78.77

1.69%

SAST

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI …

BSE India

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on January 18, 2025 for Shree Kishoriju Trading and Investments Pvt Ltd

pdf

Mangalam Drugs and Organics Ltd.

17 Jan 2025

78.77

1.69%

Company Update

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) …

BSE India

Certificate under Regulation 74 of SEBI (Depositories and Participants) Regulations, 2018 received from MUFG Intime India Private Limited formerly known as Link Intime India Private Limited for the quarter ended 31st December, 2024

pdf

Mangalam Drugs and Organics Ltd.

16 Jan 2025

78.77

1.69%

Company Update

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Update On Regulation 30 Read With Schedule II …

BSE India

Update on Regulation 30 read with Schedule III Part A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding upgrade in CRISIL Rating Long Term BBB-/Stable and Short Term Rating- A3

pdf

Mangalam Drugs and Organics Ltd.

16 Jan 2025

78.77

1.69%

Company Update

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Credit Rating

BSE India

Update as per Regulation 30 read with Schedule III Part A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding upgrade in CRISIL Rating for Long Term as BBB-/Stable and for short Term Rating- Crisil A3.

pdf

Is Mangalam Drugs and Organics Ltd. worth buying?

99 Votes:

Buy 78.79%

Sell 15.15%

Hold 6.06%